Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria.
(2020) Acta Gastro-Enterologica Belgica — Vol. 83, n° 4, p. 513-515 (2020)
Files
ActaGastroBelg2020MAFLDeditorial.pdf
Open Access - Adobe PDF
- 264.13 KB
Details
- Authors
- Abstract
- (en) Don’t say NAFLD anymore but MAFLD (“metabolic” instead of “non-alcoholic”) (1,2) ! This liver disease, which is the most frequent cause of elevated liver tests in our country, finally has an appropriate name. Until recently, MAFLD was a diagnosis of exclusion, in a patient with more than 5% steatotic hepatocytes at the liver histology and after having ruled out the consumption of alcoholic beverages but also other rarer causes (such as viral hepatitis infection, drugs, auto-immune disorders...). The different non-invasive techniques for the detection of steatosis described in our guidance document (3) are now possible for this new positive diagnosis of MAFLD (Table).
- Affiliations
Citations
Lanthier, N., & Vanuytsel, T. (2020). Metabolic dysfunction-associated fatty liver disease: a new clearer nomenclature with positive diagnostic criteria. Acta Gastro-Enterologica Belgica, 83(4), 513-515. https://hdl.handle.net/2078.5/168023 (Original work published 2020)